Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Immunotherapy × olaparib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 19 Breast Neoplasms 18 Fallopian Tube Neoplasms 9 Prostatic Neoplasms 7 Neoplasm Metastasis 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Small Cell Lung Carcinoma 4 Stomach Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Glioma 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Solid Tumors 2 Sarcoma 2 Peritoneal Neoplasms 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Metastatic Castration-resistant Prostate Cancer 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Squamous Cell 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1

Interventions

tremelimumab 1 olaparib 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04169841 2024-02-13

GUIDE2REPAIR

Centre Georges Francois Leclerc

Phase 2 Active not recruiting

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡